Cue BiopharmaReports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024 16:30 ET | Source: Cue Biopharma, Inc. BOSTON, Mass.,…
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024 13:30 ET | Source: 89bio, Inc. SAN FRANCISCO, Nov.…
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical…
Cue BiopharmaReports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024 16:30 ET | Source: Cue Biopharma, Inc. BOSTON, Mass.,…
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024 13:30 ET | Source: 89bio, Inc. SAN FRANCISCO, Nov.…
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 19:04 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Nov.…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 19:04 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Nov.…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET | Source: LENSAR, Inc. ORLANDO, Fla., Nov.…